Advancements and Challenges in Stem Cell-Based Treatments for Peripheral Nerve Regeneration

Introduction

Peripheral nerve injuries (PNIs) represent a significant clinical challenge due to their high incidence and the severe functional impairments they cause. These injuries often result from traumatic events such as accidents or surgical procedures and can lead to substantial morbidity because of the limited regenerative capacity of the peripheral nervous system. The annual incidence of traumatic PNIs is estimated to be about 13.9 per 100,000 people in developed countries, underscoring the widespread nature of this problem (Taylor et al., 2008).

Traditional therapeutic approaches, including surgical nerve repair and physical rehabilitation, often fall short of achieving complete functional recovery. The outcomes of surgical interventions can be highly variable, with many patients experiencing persistent deficits in sensory and motor function (Fox et al., 2015). Consequently, there is a pressing need for innovative treatments that can enhance nerve regeneration and functional restoration.

Recent advancements in cell-based therapies, particularly those involving stem cells, have shown promising potential in addressing the limitations of conventional PNI treatments. Stem cells, owing to their self-renewal capabilities and multipotency, offer a versatile tool for promoting tissue repair and regeneration. Among various stem cell types, mesenchymal stem cells (MSCs) and Schwann cells have garnered significant attention due to their roles in modulating the microenvironment and supporting axonal growth (Kubiak et al., 2019; Zhang et al., 2021).

MSCs, derived from various tissues, including bone marrow, adipose tissue, and dental pulp, have been shown to possess immunomodulatory properties and the ability to secrete neurotrophic factors that promote nerve regeneration (Yousefi et al., 2019). Schwann cells, the primary glial cells of the peripheral nervous system, play a critical role in myelination and axonal support. Schwann cell transplantation has demonstrated the potential to enhance axonal regeneration and remyelination in preclinical models (Pisciotta et al., 2019).

This scoping review aims to systematically explore and synthesise the existing literature on stem cell therapies for peripheral nerve injuries. By examining the current state of research, this review seeks to identify key findings, gaps in knowledge, and future directions for the clinical application of stem cell-based interventions in PNI treatment. Specifically, the review will focus on the efficacy, safety, and mechanisms of action of various stem cell therapies in promoting nerve regeneration.

Methodology

This scoping review aims to systematically explore and synthesise the existing literature on stem cell therapies for peripheral nerve injuries (PNIs). The methodology follows the framework outlined by Arksey and O’Malley (2005), encompassing the following stages: identifying the research question, identifying relevant studies, study selection, charting the data, and collating, summarising, and reporting the results.

1. Identifying the Research Question

The primary research question guiding this review is: "What is the current state of research on stem cell therapies for peripheral nerve injuries, and what are the key findings, gaps, and future directions in this field?"

2. Identifying Relevant Studies

To identify relevant studies, we utilised Elicit.org, an AI-based research assistant that helps in literature review processes. The search strategy included keywords such as "stem cell therapy," "peripheral nerve injuries," "mesenchymal stem cells," "Schwann cells," and "nerve regeneration." We applied these keywords to multiple databases, including PubMed, Scopus, and Web of Science, ensuring comprehensive coverage of the literature.

3. Study Selection

The inclusion criteria for this review were as follows:

• Articles published in peer-reviewed journals.
• Studies focusing on the use of stem cell therapies for treating PNIs.
• Both preclinical and clinical studies.
• Publications in English.

Exclusion criteria included:

• Articles not directly related to PNIs.
• Reviews, editorials, and opinion pieces.
• Non-English publications.

Elicit.org was used to screen the search results. The platform's AI capabilities facilitated the initial screening by filtering articles based on relevance and inclusion criteria. Two reviewers independently assessed the titles and abstracts of the identified articles. Full-text screening was conducted for articles that met the inclusion criteria, resolving discrepancies through discussion.

4. Charting the Data

Data extraction was performed using a standardised form to capture critical information from each included study. The extracted data included the study's title, authors, publication year, study design, type of stem cells used, outcomes measured, and main findings.

5. Collating, Summarising, and Reporting the Results

The main findings and discussion were synthesised using ChatGPT, an advanced AI language model. ChatGPT was employed to generate summaries and thematic analyses of the extracted data. The AI-assisted synthesis included identifying common themes, highlighting significant findings, and noting gaps in the literature. The research team reviewed and validated the final synthesis to ensure accuracy and coherence.

?6. Limitations

Potential limitations of this review include reliance on the accuracy of AI-based tools for screening and synthesis, which may introduce biases. Additionally, the review is limited to articles published in English, potentially overlooking relevant studies in other languages.

?Results

Main Findings

The scoping review reveals several key insights into using stem cell therapies for peripheral nerve injuries, highlighting their potential efficacy, mechanisms, and areas for further research.

1. Efficacy of Stem Cell Therapies

Numerous studies have demonstrated the potential of stem cell therapies to enhance peripheral nerve regeneration. Mesenchymal stem cells (MSCs) have shown promise due to their immunomodulatory properties and ability to secrete neurotrophic factors that support nerve repair. For instance, MSCs derived from bone marrow and adipose tissue have been reported to improve functional recovery in animal models of PNI (Yousefi et al., 2019; Zhang et al., 2021). Similarly, dental pulp-derived stem cells have been noted for their capacity to differentiate into Schwann-like cells and promote axonal growth (Pisciotta et al., 2019).

2. Mechanisms of Action

The therapeutic mechanisms of stem cells in PNI treatment primarily involve modulation of the injury microenvironment and direct support of axonal regeneration. MSCs exert their effects through paracrine signalling, releasing growth factors such as nerve growth factor (NGF), brain-derived neurotrophic factor (BDNF), and glial cell line-derived neurotrophic factor (GDNF) (Yousefi et al., 2019). These factors are critical in enhancing neuronal survival, axonal sprouting, and remyelination. Schwann cells, the glial cells of the peripheral nervous system, are essential for myelination and axonal support. Transplanted Schwann cells have been shown to integrate into injured nerve sites, aiding regeneration (Kubiak et al., 2019).

3. Safety and Feasibility

Various preclinical studies have evaluated stem cell therapies' safety and feasibility. MSCs and Schwann cells have generally exhibited favourable safety profiles, with minimal adverse effects reported. However, the long-term safety and potential for tumorigenicity require further investigation, particularly as these therapies move towards clinical applications (Zhang et al., 2021).

4. Challenges and Limitations

Despite the promising results, several challenges and limitations remain. One significant hurdle is the variability in the sources and quality of stem cells, which can affect therapeutic outcomes. The optimal delivery methods and dosages for stem cell therapies are also under investigation. Ensuring consistent and efficient cell engraftment and survival in the hostile environment of injured nerves is another critical challenge (Pisciotta et al., 2019).

5. Future Directions

Future research should focus on standardising stem cell preparation and delivery protocols to enhance reproducibility and clinical translation. Investigating the synergistic effects of combining stem cell therapies with other regenerative approaches, such as biomaterials and pharmacological agents, could also yield improved outcomes. Moreover, advancing our understanding of the molecular mechanisms underlying stem cell-mediated nerve repair will be crucial for optimising these therapies (Kubiak et al., 2019; Zhang et al., 2021).

Discussion

Summary of Discussions

The discussions within the reviewed literature reflect a nuanced understanding of the potential and challenges associated with stem cell therapies for peripheral nerve injuries (PNIs). Several key themes emerged, highlighting the current state of research, clinical implications, and future directions.

1. Current Advancements and Promising Results

The discussions across multiple studies emphasise the promising results achieved with various types of stem cells, particularly mesenchymal stem cells (MSCs) and Schwann cells. These cells have shown significant potential in preclinical models for enhancing nerve regeneration and functional recovery. For instance, MSCs derived from bone marrow and adipose tissue have successfully promoted axonal growth and remyelination through the secretion of neurotrophic factors (Yousefi et al., 2019). Additionally, dental pulp-derived stem cells have demonstrated the ability to differentiate into Schwann-like cells, further supporting nerve repair (Pisciotta et al., 2019).

2. Mechanisms of Stem Cell-Mediated Repair

The discussions provide insights into the mechanisms through which stem cells facilitate nerve regeneration. MSCs are noted for their paracrine effects, releasing a variety of growth factors such as nerve growth factor (NGF), brain-derived neurotrophic factor (BDNF), and glial cell line-derived neurotrophic factor (GDNF), which play crucial roles in neuronal survival and axonal regeneration (Yousefi et al., 2019). Schwann cells, critical for myelination in the peripheral nervous system, support axonal regrowth and modulate the local microenvironment to enhance repair processes (Kubiak et al., 2019).

3. Clinical Translation and Safety Considerations

The transition from preclinical findings to clinical application is a recurrent topic. Discussions highlight the need for rigorous clinical trials to establish the safety, efficacy, and optimal protocols for human stem cell therapies. Although preliminary studies suggest that MSCs and Schwann cells have favourable safety profiles, long-term effects and the risk of tumorigenicity remain areas of concern that must be thoroughly investigated (Zhang et al., 2021). The standardisation of stem cell sources, preparation methods, and delivery techniques is critical for reproducibility and clinical success.

4. Challenges and Barriers to Implementation

Several challenges are discussed, including the variability in stem cell quality and the complexities of achieving efficient cell engraftment and survival in the hostile environment of injured nerves. The heterogeneity in experimental designs and outcome measures across studies also poses a barrier to directly comparing results and drawing definitive conclusions (Pisciotta et al., 2019). Addressing these issues requires collaborative efforts to standardise research methodologies and establish comprehensive guidelines for stem cell therapy in PNIs.

5. Future Research Directions

The discussions underscore the importance of continued research to refine stem cell therapies and explore their full potential. Future studies should focus on enhancing the understanding of the molecular mechanisms underlying stem cell-mediated nerve repair and investigating the synergistic effects of combining stem cell therapy with other treatments, such as biomaterials and pharmacological agents. Developing innovative delivery systems to improve stem cell engraftment and survival in the injury site is crucial (Kubiak et al., 2019; Zhang et al., 2021).

Conclusion

In summary, the discussions within the reviewed literature highlight the significant progress made in stem cell therapies for PNIs while acknowledging the remaining challenges. The continued advancement of this field holds the potential to transform the treatment landscape for peripheral nerve injuries, providing hope for improved outcomes in patients.

References

• Kubiak, C. A., Grochmal, J., Kung, T. A., Cederna, P. S., Midha, R. (2019). "Stem-cell–based therapies to enhance peripheral nerve regeneration." Muscle and Nerve, 60(1), 7-15.
• Pisciotta, A., Bertoni, L., Vallarola, A., Bertani, G., Mecugni, D., De Biasi, S., Orioli, E., Carnevale, G., Bruzzesi, G., De Pol, A., Maraldi, T. (2019). "Neural crest derived stem cells from dental pulp and tooth-associated stem cells for peripheral nerve regeneration." Neural Regeneration Research, 14(12), 2107-2115.
• Yousefi, F., Lavi Arab, F., Karim, B., Mardpour, S., Ebrahimi, M., Shamdani, S., Jafarian, M., Hassani, S. N., Ghanian, M. H., Nasr-Esfahani, M. H., Baharvand, H. (2019). "Novel approaches using mesenchymal stem cells for curing peripheral nerve injuries." Life Sciences, 221, 1-14.
• Zhang, R.-C., Du, W.-Q., Zhang, J.-Y., Yu, S.-X., Wang, H.-L., Zhang, S.-H. (2021). "Mesenchymal stem cell treatment for peripheral nerve injury: a narrative review." Neural Regeneration Research, 16(11), 2172-2180.

?